NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancer and fibrosis, today reported its financial results for the first quarter of fiscal 2009. These results are included in the Company’s Quarterly Report on Form 10-Q for the three-month period ended March 31, 2009, which has been filed with the SEC.
